ArticlePharmaceuticals (Basel, Switzerland)2023

Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer: Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation.

Eid E Salama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.